Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Company's Board of... (objective to enhance performance such as...)

Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Company's Board of Directors

Date:2/12/2008

objective to enhance performance, such as improving efficacy, safety and compliance.

This press release contains forward-looking statements that reflect the company's current views as to its board of directors and business prospects. These forward-looking statements involve risks and uncertainties, including but not limited to: (i) the company's proprietary product candidates and those of certain of its partners are in the early phases of clinical development and the risk of failure is high and can occur at any stage prior to regulatory approval, (ii) the company's or its partner's ability to obtain regulatory approval for product candidates, (iii) the success of the company's partners in sales and marketing efforts to generate from approved products and future products (if any), and (iv) the company's patent applications for its technology platforms and proprietary or partner product candidates may not issue, patents that have issued may not be enforceable, or intellectual property licenses from third parties may be required in the future. Important risks and uncertainties are detailed in the company's reports and other filings with the Securities and Exchange Commission, including its most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K. Actual results could differ materially from the forward-looking statements contained in this press release. The company undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts:

Tim Warner (650) 283-4915 or twarner@nektar.com

Stephan Herrera (415) 488-7699 or sherrera@nektar.com

Jennifer Ruddock (650) 631-4954 or jruddock@nektar.com

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
2. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
3. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
4. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
7. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
8. Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
9. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
10. Anesiva Appoints Daniel Janney to Board of Directors
11. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations

Post Your Comments:

(Date:6/19/2013)... Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer ... infectious diseases, announced today that Jeffrey Riley , CEO, ... York Conference on Thursday, June 27, 2013 at The Metropolitan ... Riley is scheduled to present at 8:40 a.m. (Eastern Time). ... be accessed by logging onto the web at http://onemedplace.com/forum/webcast/ ...

(Date:6/19/2013)... -- NineSigma , Inc., of Cleveland ... NineSights.com is now the innovation engine for ... community of innovators. From technology developers, to ... stands out for its large community of innovators in ... all vetted by NineSigma. The community is free to ...

(Date:6/19/2013)... LOS ANGELES , June 19, 2013 Biotechnology ... is teaming up with financial software provider BlackLine Systems ... (NYSE: SAP ) for a webinar next week ... Amgen Uses Solutions from BlackLine and SAP to Help Keep ... (Logo: http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, ...

(Date:6/19/2013)... 2013 India’s vast and growing ... be worth up to a billion dollars per ... government is taking serious action to better regulate ... This presentation will examine:, , Recent ... Immediate and long term impacts , Foreseeable ...

Breaking Biology Technology:Synthetic Biologics to Present at OneMedForum New York 2013 2 NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2 NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3 Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2 Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3 Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4

[0] Synthetic Biologics to Present at OneMedForum New York 2013 [0] NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights [0] Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations [0] Navigating the Dynamic Indian Clinical Trial Landscape, New Webinar Hosted by Xtalks

... JERSEY CITY, New Jersey, October 29, Rosetta Genomics ... of microRNA-based diagnostics, announced today its,management will present ... 3-4, 2008 at the Waldorf-Astoria Hotel in New ... recently discovered, naturally occurring, small,RNAs that act as ...

... Inverness Medical,Innovations, Inc. (Amex: IMA ), a ... financial results for the quarter,ended September 30, 2008., ... net revenue of,$438.8 million compared to net revenue of ... increase was primarily due to $118.7 million,of incremental revenue ...

... Oct. 29 The Healthcare Scoop,( http://www.healthcarescoop.com ... patient stories about healthcare, will now extend ... organizations, according,to MaryAnn Stump, president, Consumer Aware. ... including Courage Center, Mayo,Clinic, The Emily Program, ...

Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference Inverness Medical Innovations Announces Third Quarter 2008 Results Healthcare Scoop Expands Consumer Conversation to Dialogue with Premier Healthcare Organizations

(Date:6/19/2013)... canary seeds bred specifically for human consumption qualifies as ... with celiac disease (CD), scientists have confirmed in a ... Food Chemistry . , Joyce Irene Boye and ... in the United States alone have CD. They develop ... and other grains that contain gluten-related proteins. Boye,s team ...

(Date:6/19/2013)... In fall 2012, the European Medicines Agency (EMA) ... the first ever gene therapy for clinical use ... company, had developed AAV-LPL S447X for the treatment ... lipase deficiency (LPLD) which affects approximately one or ... causes severe, life-threatening inflammations of the pancreas. Afflicted ...

(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...

Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2 UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2

[0] New canary seed is ideal for gluten-free diets in celiac disease [0] No danger of cancer through gene therapy virus [0] UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline

... of cardiac therapeutics have long looked to the future when ... one,s own heart cells. A study published in the February ... American Heart Association, shows that heart stem cells from children ... heart in an animal model. ...

... of Exeter has revealed that couples with similar personalities make ... least in the world of zebra finches. Researchers found ... a willingness to explore, did a much better job of ... were markedly different in personality, chicks didn,t fare as well ...

... For the first time, scientists have mapped the genome--the genetic ... efforts to maintain the genetic diversity of captive and wild ... be used to help improve our understanding of the evolution ... National Science Foundation, the orangutan study appears in the Jan. ...

Cached Biology News:Using a child's own stem cells to repair their heart looks promising 2 Opposites may attract, but they don't make better parents 2 Scientists determine what makes an orangutan an orangutan 2 Scientists determine what makes an orangutan an orangutan 3

Using a child's own stem cells to repair their heart looks promising Opposites may attract, but they don't make better parents Scientists determine what makes an orangutan an orangutan

... MW 140kDa GenBank Accession ... spanning amino acids 926-941 (DKKVKPPFIPTIRGRE) of human ... Quality Assurance Routinely evaluated ... cells. Stability 1 year ...

Replacement Parts for Electrophoresis Apparatus...

Rabbit anti-phospho-EGFr (Tyr992) - Concentrate...

EMBP (FL-222)...

Biology Products:

Rabbit Anti-PRK2 Polyclonal Antibody, Unconjugated from Upstate Buffer Core w/ Electrodes for XCell SureLock and XCell II from Invitrogen Rabbit Anti-Human EGFr, phospho (Tyr992) Concentrate Polyclonal Antibody, Unconjugated from Invitrogen Rabbit Anti-Human EMBP Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.